ERLOCIP 150 MG: Erlocip tablets consist of active ingredients known as Erlotinib, that is considered as quinazoline derivative and anti-cancer agents that responses as a protein kinase prohibitors for EGFR related to tyrosine kinase. Erlocip is majorly used in the treatment of non-small cell lung cancer and pancreatic carcinoma and also involved to treat various […]

Read More →